DE69821347D1 - (2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitrile als zwischenprodukte und verfahren zu ihrer herstellung - Google Patents

(2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitrile als zwischenprodukte und verfahren zu ihrer herstellung

Info

Publication number
DE69821347D1
DE69821347D1 DE69821347T DE69821347T DE69821347D1 DE 69821347 D1 DE69821347 D1 DE 69821347D1 DE 69821347 T DE69821347 T DE 69821347T DE 69821347 T DE69821347 T DE 69821347T DE 69821347 D1 DE69821347 D1 DE 69821347D1
Authority
DE
Germany
Prior art keywords
thienyl
ethylamino
halophenyl
acetonitrile
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69821347T
Other languages
English (en)
Other versions
DE69821347T2 (de
Inventor
Alain Heymes
Bertrand Castro
Maria Bakonyi
Nagy Marianna Csatarine
Leventene Molnar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE69821347D1 publication Critical patent/DE69821347D1/de
Application granted granted Critical
Publication of DE69821347T2 publication Critical patent/DE69821347T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
DE69821347T 1997-05-13 1998-05-11 (2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitrile als zwischenprodukte und verfahren zu ihrer herstellung Expired - Lifetime DE69821347T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9700886A HU225504B1 (en) 1997-05-13 1997-05-13 Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HU9700886 1997-05-13
PCT/HU1998/000046 WO1998051682A1 (en) 1997-05-13 1998-05-11 New intermediates and process for the preparation thereof

Publications (2)

Publication Number Publication Date
DE69821347D1 true DE69821347D1 (de) 2004-03-04
DE69821347T2 DE69821347T2 (de) 2004-12-02

Family

ID=89995121

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821347T Expired - Lifetime DE69821347T2 (de) 1997-05-13 1998-05-11 (2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitrile als zwischenprodukte und verfahren zu ihrer herstellung

Country Status (14)

Country Link
US (1) US6215005B1 (de)
EP (1) EP0981525B1 (de)
JP (1) JP4279903B2 (de)
AT (1) ATE258551T1 (de)
AU (1) AU7444698A (de)
BR (1) BR9809113B1 (de)
CA (1) CA2288637C (de)
DE (1) DE69821347T2 (de)
DK (1) DK0981525T3 (de)
ES (1) ES2213900T3 (de)
HU (1) HU225504B1 (de)
NO (1) NO325305B1 (de)
PT (1) PT981525E (de)
WO (1) WO1998051682A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
EP1603920A1 (de) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorphe und amorphe form (s)-(+)-clopidogrel-bisulfat
US20040250673A1 (en) * 2003-06-10 2004-12-16 Salerno Paul Michael Ergonomic pedal board
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1680430B1 (de) 2003-11-03 2010-01-20 Cadila Healthcare Ltd. Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
TW200640932A (en) * 2005-02-24 2006-12-01 Teva Pharma Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
EP1902058A2 (de) 2005-07-12 2008-03-26 RPG Life Sciences Limited Verfahren für die zubereitung von methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-essigsäuremethylester oder salzen daraus mit höherer chiraler reinheit und produkte daraus
KR20090013794A (ko) * 2006-04-27 2009-02-05 인드-스위프트 래버러토리즈 리미티드 클로피도그렐 히드로겐 설페이트의 다형태의 제조방법
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
EP1980563A1 (de) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Verfahren zur Herstellung von Methyl (+)-(S)-Alpha-(O-Chlorophenyl)-6,7-Dihydrothieno-[3,2-C]pyridine-5(4H) Acetat
EP2346879A1 (de) * 2008-10-24 2011-07-27 Sandoz AG Verfahren zur herstellung von s-clopidogrel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508455A1 (fr) 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de derives des (thienyl-2)- et (thienyl-3)-2 ethylamines
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2614619B1 (fr) 1987-04-29 1989-09-15 Sanofi Sa Procede de preparation de n-((chloro-2)-benzyl) (thienyl-2)-2 ethylamine
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
CA2265886A1 (en) * 1996-09-12 1998-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines

Also Published As

Publication number Publication date
HUP9700886A2 (hu) 1999-09-28
NO995531D0 (no) 1999-11-12
BR9809113A (pt) 2000-08-01
AU7444698A (en) 1998-12-08
US6215005B1 (en) 2001-04-10
NO995531L (no) 1999-12-13
NO325305B1 (no) 2008-03-25
EP0981525B1 (de) 2004-01-28
PT981525E (pt) 2004-05-31
ES2213900T3 (es) 2004-09-01
HU225504B1 (en) 2007-01-29
DE69821347T2 (de) 2004-12-02
WO1998051682A1 (en) 1998-11-19
JP2001525817A (ja) 2001-12-11
BR9809113B1 (pt) 2010-03-09
EP0981525A1 (de) 2000-03-01
CA2288637C (en) 2005-11-15
DK0981525T3 (da) 2004-05-10
CA2288637A1 (en) 1998-11-19
ATE258551T1 (de) 2004-02-15
JP4279903B2 (ja) 2009-06-17
HU9700886D0 (en) 1997-07-28
HUP9700886A3 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
DE69821347D1 (de) (2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitrile als zwischenprodukte und verfahren zu ihrer herstellung
DE69813792D1 (de) Zwischenprodukte und verfahren zu ihrer herstellung
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
DE59606920D1 (de) Chirale methylphenyloxazolidinone
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
NO20016151L (no) Fremstilling av substituerte piperidin-4-oner
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
BR9909151A (pt) processos para preparação de intermediários
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
BR9807785A (pt) Processo para a preparação do composto, e, composto
ATE196292T1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
YU22797A (sh) Postupak i intermedijarna jedinjenja za dobijanje pesticidnih fluoroolefinskih jedinjenja
DE60006125D1 (de) Herstellung von 2-(2-arylmorpholin-2-yl)ethanolderivaten und zwischenprodukte
DE60000790D1 (de) [(2-substituierte-5-[3-thienyl)-benzyl]-[2-([2-isopropoxy-5-fluoro]-phenoxy)-ethyl]-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente
ATE244217T1 (de) Herstellung von beta-mehtylcarbapenem- zwischenprodukten
AU1392600A (en) Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid useful as intermediates
HU9600476D0 (en) Benzothiophene compounds, intermediates, compositions, and process for their production
DK1070082T3 (da) Fremgangsmåde til fremstilling af 4,4-dimethyl-5alfa-cholesta-8,14,24-trien-3beta-ol og mellemprodukter i fremgangsmåden (I)
DK1444244T3 (da) Fremgangsmåde til fremstilling af desclarithromycin, samt mellemprodukter
NO993650L (no) Nye forbindelser med hemoregulerende effekt
NO20006377L (no) Syntese av benzo[F]kinolinoner

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 981525

Country of ref document: EP

Representative=s name: BEETZ & PARTNER PATENT- UND RECHTSANWAELTE, DE